Dependence on the MD8000 Series and Risk of Delayed Transition to Successor Products
First written in FY2016. 5 of 10 entries say "Restated". Latest entry: FY2025.
The whole theme swung hardest in 2017: 2 of 11 companies on the "Worse" side.
8 other companies' latest entry also says "Mitigated".
- FY2025MitigatedAnnual report
「Accordingly, the Group began selling Xscend®, the new model it had been developing as the successor to the MD8000 series.」
In addition to the start of sales of Xscend®, the successor to MD8000, adoption and deliveries to multiple domestic and overseas customers progressed, giving concrete shape to the transition to the successor product. However, the disclosure does not state that the risk associated with dependence on MD8000 has been eliminated. - FY2025-H1MitigatedAnnual report
「We began selling the new product Xscend® in April 2023, have proposed it to existing customers in response to their demand for equipment upgrades, and have already delivered it to several companies.」
The launch of Xscend®, the successor to MD8000, along with deliveries to multiple companies and adoption at a major international event, shows concrete progress toward transitioning to the successor product. However, the disclosure does not state that the risk associated with dependence on MD8000 has been eliminated. - FY2023RestatedAnnual report
「Accordingly, the Group decided to sell Xscend®, the new model it had been developing as the successor to the MD8000 series. However, if the market launch of Xscend® is delayed or competitors develop innovative technologies or launch new products, the Group's sales may decline.」
The risk associated with the Group's high dependence on MD8000 continues, but Xscend® was identified as its successor and the decision to sell it was disclosed. At the same time, delays in the market launch were explicitly identified as a new risk. - FY2022RestatedAnnual report
「The Group's sales continue to be highly dependent on the MD8000 series of IP transmission equipment.」
The Company continued to identify its high dependence on the MD8000 series and the gradual erosion of its competitive advantage as risks. At the same time, it is proceeding with the development of additional functions and successor models. - FY2021RestatedAnnual report
「The Group's sales continue to be highly dependent on the MD8000 series of IP transmission equipment.」
The Company continued to identify its high dependence on the MD8000 series and the gradual erosion of its competitive advantage as risks, while planning the development of additional functions and new products. - FY2019RestatedAnnual report
「The Group's sales continue to be highly dependent on the MD8000 series of IP transmission equipment.」
While continuing to identify its high dependence on the MD8000 series as a risk, the Company is proceeding with the launch of MD-003 and the development of new products. - FY2018RestatedAnnual report
「The Group's sales continue to be highly dependent on the MD8000 series of IP transmission equipment. The MD8000 series … continues to outperform competitors in terms of performance, but … its overwhelming competitive advantage has gradually diminished.」
The Company continued to identify its high dependence on the MD8000 series and the gradual erosion of its competitive advantage as risks, while planning the development of additional functions and new products. - FY2017WorsenedAnnual report
「Nearly 9 years have passed since the first shipment of the MD8000 series, and its overwhelming competitive advantage has gradually diminished, creating the possibility that it may no longer be able to adequately adapt to new market needs.」
The period since the launch of the core MD8000 series increased from nearly 8 years to nearly 9 years, making the risks of product aging, declining competitiveness and delays in launching new products even more explicit. - FY2017-Q3MaterialisedAnnual report
「The Group expanded its business mainly overseas, centered on the MD8000 series. Sales in North America remained steady, while the Australian market fell well below the previous year's results because of the impact of demand reaching maturity. Sales in the domestic market increased from the previous year, but new business development in Asia and Europe did not progress because of delays in developing new products.」
While the MD8000 series remained the mainstay, the specific impact of the transition risk emerged as delays in developing successor and new products prevented progress in new business development in Asia and Europe. - FY2016First statedAnnual report
「Nearly 8 years have passed since the first shipment of the MD8000 series, and its overwhelming competitive advantage has gradually diminished, creating the possibility that it may no longer be able to adequately adapt to new market needs.」
In addition to dependence on its core product, the Company disclosed the risks associated with the time elapsed since the start of product shipments and delays in launching successor products.